Literature DB >> 31895145

Investigation of factors associated with spontaneous preterm birth in pregnant women living with HIV.

Arianne Y K Albert1,2, Chelsea Elwood1,2, Emily C Wagner1, Zahra Pakzad1, Tessa Chaworth-Musters3, Kyra Berg1, Julie Van Schalkwyk1,2, Evelyn J Maan2, Arezou Azampanah2, Elisabeth McClymont2, Ariane Alimenti4, John C Forbes4, Deborah M Money1,2.   

Abstract

OBJECTIVE: To investigate factors contributing to preterm birth (PTB), including cART use and clinical and social determinants of health, in women living with HIV (WLWH) from British Columbia, Canada.
DESIGN: Retrospective observational cohort.
METHODS: We investigated the effect of cART use and other clinical and demographic factors on spontaneous PTB (sPTB) rates (<37 weeks gestational age) among 631 singleton pregnancies between 1997 and 2018. Exposure to cART was modelled in comparison to no exposure, exposure in the first trimester, and between regimens. Differences in sPTB risk were estimated using time-dependent Cox's proportional hazards models.
RESULTS: Overall, the sPTB rate was 16%. Cumulative cART use was associated with lower risk of PTB (Wald test P = 0.02; hazard ratio = 0.98, 95% CI = 0.96-0.99) and specific cART regimens were not associated with increased risk of sPTB. Exposure in the first trimester was not associated with sPTB and for each week of cART exposure, the risk of sPTB decreased by 2%. In a multivariable model, HIV viral load and substance use remained associated with risk of sPTB, but not cART exposure.
CONCLUSION: The sPTB rate among pregnant WLWH was more than three times higher than in the general population. However, sPTB was not related specifically to use of cART; in fact, cART appeared to reduce the risk of sPTB. Uncontrolled HIV replication and substance use were associated with increased risk of sPTB among pregnant WLWH. This emphasizes the important role of prenatal care, access to cART, and smoking cessation and harm reduction to reduce the risk of sPTB in WLWH.

Entities:  

Year:  2020        PMID: 31895145     DOI: 10.1097/QAD.0000000000002464

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.

Authors:  Kartik K Venkatesh; Andrew Edmonds; Daniel Westreich; Jodie Dionne-Odom; Deborah Jones Weiss; Anandi N Sheth; Helen Cejtin; Dominika Seidman; Seble Kassaye; Howard Minkoff; Jessica Atrio; Lisa Rahangdale; Adaora A Adimora
Journal:  HIV Med       Date:  2021-09-12       Impact factor: 3.094

2.  Prevalence trends and risk factors associated with HIV, syphilis, and hepatitis C virus among pregnant women in Southwest China, 2009-2018.

Authors:  Shanmei Zhong; Yanyun Ou; Fei Zhang; Zhaosen Lin; Rongye Huang; Aidan Nong; Zhenxian Wu; Huayue Liang; Cai Qin; Qiuyu Wei; Yuan Yang; Dee Yu; Xianyan Tang; Li Ye; Deping Liu; Hao Liang; Bingyu Liang
Journal:  AIDS Res Ther       Date:  2022-06-27       Impact factor: 2.846

Review 3.  Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy.

Authors:  Amanda J Jones; Uzoamaka A Eke; Ahizechukwu C Eke
Journal:  Expert Rev Anti Infect Ther       Date:  2022-03-01       Impact factor: 5.854

4.  Marijuana, Opioid, and Alcohol Use Among Pregnant and Postpartum Individuals Living With HIV in the US.

Authors:  Lynn M Yee; Deborah Kacanek; Chase Brightwell; Lisa B Haddad; Jennifer Jao; Kathleen M Powis; Tzy-Jyun Yao; Emily Barr; Carly Broadwell; Suzanne Siminski; George R Seage; Ellen G Chadwick
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis.

Authors:  Imogen Cowdell; Katharina Beck; Clara Portwood; Harriet Sexton; Mary Kumarendran; Zoe Brandon; Shona Kirtley; Joris Hemelaar
Journal:  EClinicalMedicine       Date:  2022-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.